Drug Profile
Research programme: Staphylococcus aureus infections - BioResearch/Inhibitex
Latest Information Update: 20 Jul 2007
Price :
$50
*
At a glance
- Originator BioResearch Ireland
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Staphylococcal infections
Most Recent Events
- 28 Jul 2004 Preclinical trials in Staphylococcal infections in Ireland (unspecified route)
- 26 Jul 1999 Preclinical development for Staphylococcal infections in Ireland (unspecified route)